Literature DB >> 11771869

Abnormal rheology in cyanotic congenital heart disease--a factor in non-immune nephropathy.

S Dittrich1, K Kurschat, P E Lange.   

Abstract

OBJECTIVE: There are few data on non-immune nephropathy in cyanotic congenital heart disease reported in the literature. Rheologic changes have been suspected to be involved in the pathogenesis. This study was performed to describe the characteristics of renal functional and hemorheological abnormalities in a large group of patients with cyanotic congenital heart disease. PATIENTS AND METHODS: Thirty-five cyanotic patients with median oxygen saturation of 82% (range 38-92%), age 18 years (range 5-63 years), and 13 acyanotic controls with atrial septal defect, age 37 years (range 20-66 years) were included. Red cell indices, blood and plasma viscosity were analyzed. Renal function was evaluated with measurements of albumin, alpha1-microglobulin, transferrin, immunoglobuline, and N-acetyl-beta-D-glucosaminidase in the urine.
RESULTS: Fifteen cyanotic patients and 1 control patient had pathologic albuminuria (p < 0.05). In cyanotic patients blood and plasma viscosity, erythrocyte count, hemoglobin, and hematocrit were elevated while mean corpuscular volume and mean corpuscular hemoglobin were decreased (p < 0.05). The possible impact of blood hyperviscosity on proteinuria is indicated by multiple regression analysis (odds ratio = 0.5, confidence intervals 22-130, p < 0.05).
CONCLUSIONS: Our study shows a coincidence of elevated blood viscosity and proteinuria in patients with cyanotic congenital heart disease. This observation supports the hypothesis that impaired peritubular capillary blood flow with increased intraglomerular blood pressure may add to chronic glomerular dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11771869     DOI: 10.1080/003655901753224486

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  7 in total

1.  Repeated phlebotomies improve and stabilise renal function in cyanotic nephropathy.

Authors:  Kennedy O Omonuwa; Arunabh Talwar; Sophy Dedopoulos; Lionel U Mailloux
Journal:  BMJ Case Rep       Date:  2009-03-20

2.  Mechanisms of development and progression of cyanotic nephropathy.

Authors:  Jun Inatomi; Kentaro Matsuoka; Rika Fujimaru; Atsuko Nakagawa; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2006-08-11       Impact factor: 3.714

3.  Pediatric Patients Undergoing a Fontan Operation or with a High RACHS-1 Score Require Monitoring for Chronic Kidney Disease in Early Childhood.

Authors:  Koji Nakae; Kentaro Ueno; Naohiro Shiokawa; Yoshihiro Takahashi; Junpei Kawamura; Daisuke Hazeki; Yutaka Imoto; Yoshifumi Kawano
Journal:  Pediatr Cardiol       Date:  2022-01-13       Impact factor: 1.655

Review 4.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

5.  High variability of albuminuria in nondiabetic population: the Takahata Study.

Authors:  Kazuko Suzuki; Tsuneo Konta; Satoshi Takasaki; Ami Ikeda; Kazunobu Ichikawa; Hitoshi Sato; Yoko Shibata; Tetsu Watanabe; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2009-05-20       Impact factor: 2.801

6.  Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.

Authors:  Nattaphorn Hongsawong; Prapimdaw Khamdee; Suchaya Silvilairat; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

7.  Renal function in children with cyanotic congenital heart disease: pre- and post-cardiac surgery evaluation.

Authors:  Hamid Amoozgar; Mitra Basiratnia; Fatemeh Ghasemi
Journal:  Iran J Pediatr       Date:  2014-01-25       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.